Citarinostat is an oral, selective histone deacetylase 6 inhibitor that inhibits growth of solid tumor cell lines and exhibits potent synergy with Pac in preclinical studies. It is under investigation in clinical trial NCT02886065.. Reference standards of Citarinostat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => Citarinostat - API Standards [catalogue_number] => PA 56 24000 [category_ids] => ,81, [chemical_name] => [weight] => 467.95 [form] => C24H26ClN5O3 [cas] => 1316215-12-9 [pslug] => 1316215-12-9-citarinostat-api-pa5624000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 56 24000
CAS :
Molecular Formula : C24H26ClN5O3
Molecular Weight : 467.95
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....